Feb 19, 2020 | EN, medicationn, study
A study by the Scientific Institute of Private Health Insurance (WIP) concludes that, compared to other European countries, oncological drugs and so-called orphan drugs, i.e. drugs for rare diseases, are available in Germany much more quickly and comprehensively....